[18F]EF5-PET/CT显像卵巢肿瘤乏氧的可行性临床研究
该前瞻性临床研究纳入15例疑似卵巢恶性肿瘤患者,术前行[18F]EF5与[18F]FDG-PET/CT扫描,评估[18F]EF5摄取分布、总腹腔代谢肿瘤体积(TMTV)及乏氧亚体积(HSV)。结果显示[18F]EF5-PET/CT提示47%(7/15)患者存在乏氧,中位HSV为87 cm3(占TMTV的31%),但[18F]EF5在癌组织摄取低于生理排泄途径,干扰图像判读。结论认为因腹腔生理性[18F]EF5蓄积,该显像在卵巢癌临床应用中不可行,但作为FDG-PET/CT的补充可能有用。
要点
- [18F]EF5-PET/CT在47%(7/15)卵巢肿瘤患者中提示乏氧。
- 中位乏氧亚体积(HSV)为87 cm3,占TMTV的31%。
- 癌组织[18F]EF5摄取低于生理排泄途径,图像判读困难。
核心结论
- 因腹腔生理性[18F]EF5蓄积,[18F]EF5-PET/CT在卵巢癌临床显像中不可行,但作为FDG-PET/CT的补充可能有用。
研究设计与样本
- 前瞻性临床研究,纳入15例疑似卵巢恶性肿瘤患者,术前行[18F]EF5与[18F]FDG-PET/CT扫描。
- 评估[18F]EF5摄取分布、总腹腔代谢肿瘤体积(TMTV)及乏氧亚体积(HSV)。
主要发现
- [18F]EF5-PET/CT提示47%(7/15)患者存在乏氧。
- 中位HSV为87 cm3,占TMTV的31%。
- [18F]EF5摄取见于原发肿瘤,4例患者腹腔转移灶亦检出摄取。
- 癌组织[18F]EF5摄取低于生理排泄途径,增加PET/CT图像判读难度。
关键数值与推荐
- 乏氧阳性率47%(7/15),中位HSV 87 cm3(占TMTV 31%)。
临床怎么用
- 因腹腔生理性[18F]EF5蓄积限制判读,该显像不宜单独用于卵巢癌乏氧评估。
- 可考虑将[18F]EF5-PET/CT作为FDG-PET/CT的补充手段使用。
局限性
- 样本量小(15例),为单中心前瞻性研究。
- 癌组织[18F]EF5摄取低于生理排泄途径,影响图像判读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Evaluation of the feasibility of [18F]EF5-PET/CT scan in identifying hypoxic lesions in ovarian tumors in prospective clinical setting. METHODS: Fifteen patients with a suspected malignant ovarian tumor were scanned with [18F]EF5 and [18F]FDG-PET/CT preoperatively. The distribution of [18F]EF5-uptake, total intraabdominal metabolic tumor volume (TMTV), and hypoxic subvolume (HSV) were assessed. RESULTS: [18F]EF5-PET/CT suggested hypoxia in 47% (7/15) patients. The median HSV was 87 cm3 (31% of TMTV). The [18F]EF5-uptake was detected in primary tumors and in four patients also in intra-abdominal metastases. The [18F]EF5-uptake in cancer tissue was low compared to physiological excretory pathways, complicating the interpretation of PET/CT images. CONCLUSIONS: [18F]EF5-PET/CT is not feasible in ovarian cancer imaging in clinical setting due to physiological intra-abdominal [18F]EF5-accumulation. However, it may be useful when used complementarily to FDG-PET/CT.
引用
- Laasik M, Hynninen J, Forsback S, et al. The feasibility of [18F]EF5-PET/CT to image hypoxia in ovarian tumors: a clinical study. EJNMMI Res. 2020. PMID: 32910291. doi:10.1186/s13550-020-00689-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。